Loading...
HomeMy WebLinkAboutR2025-225 Fully ExecutedBOARD OF COUNTY COMMISSIONERS COUNTY OF KITTITAS STATE OF WASHINGTON RESOLUTTON No. 2o2s- Aa€ A RESOLUTION TO AUTHORIZE EXECUTION OF AN INTERLOCAL AGREEMENT BETWEEN KITTITAS COUNTY AND CITY OF ELLENSBURG FOR THE POOLING OF OPIOID FUNDS RESULTING FROM THE SETTLEMENT OF CLAIMS AGAINST PHARMACEUTICAL SUPPLY CHAIN PARTICIPANTS WHEREAS, the Interlocal Cooperation Act, as amended, and codified in Chapter 39-34 of the Revised Code of Washington ("RCW'), provides for public agencies to enter into agreements for joint or cooperative action authorized under that chapter; and WHEREAS,this Interlocal Agreement (ILA) is between Kittitas County (KC) and the City of Ellensburg (COE) for the pooling of funds received by the COE pursuant to its execution of the One Washington Memorandum of Understanding with those received by Kittitas County pursuant to its execution of the same agfeement' COE and KC are local govemments who have executed both the One Washington Mutual Memorandum of Understanding Between Washington Municipalities and the Memorandum of Understanding between the Greater Columbia Region Municipalities to Establish an Opioid Abatement Counsel to establish a framework for the distribution and oversight of Opioid Funds (as the term is defined in both agreements); and WHEREAS, the City of Ellensburg desires to pool the funds it receives with the funds Kittitas County receives in order to best serve the residents of Ellensburg and Kittitas County; and WHEREAS, it is mutually beneficial for the COE and KC to enter into this ILA; and WHEREAS. the term of the ILA shall be from the last date of signature until the COE no longer receives Opioid Funds pursuant to the above listed agreements, unless the ILA is terminatedearly or its term is extended as provided within this ILA; and WHEREAS. KC and COE agree to designate a set amount of Opioid Funds available from its settlement account for each funding cycle, will provide staff support and perform other duties as set forth in ILA, which is attached hereto and incorporated bY reference; and WHEREAS, Both parties agree that each will follow the requirement of the underlying MOUs that each has executed and agreed to abide by; and WHEREAS, Both parties agree to fund the Kittitas County Public Health Department Harm Reduction Program outside the public request for proposal process I the amount of $ 100,000.00 per year, for five (5) years, beginning January 1,2026; and WHEREAS, the point of contact for the City of Ellensburg with be Heidi Behrends Cemiwey, City Manager, and the point of contact for Kittitas County is Kasey Knutson, Human Services Manager for Kittitas County Public Health DeParlment. NOW, THEREFORE BE IT RESOLVED that the Board of county commissioners, in the best interest of the public, does hereby authorize the Boards' signature on an Interlocal Agreement between Kittitas county and the city of Ellensburg. DArEDthis lB.%day of 2025, at Ellensburg, Washington. BOARD OF COLINTY COMMISSIONERS KITTITAS COLINTY, WASHINGTON AB V of the APPROVED AS TO FORM Prosecutor/Deputy Prosecutor INTERLOCAL AGREEMENT Between KITTITAS COUNTY and The City of Ellensburg for Pooling Of Opioid Funds Resulting from the Settlement of Claims Against Pharmaceutical Supply Chain Participants This lnterlocal Agreement (hereinafter the "Agreement") is entered into by and between Kittitas County, a municipal corporation of the State of Washington, and the City of Ellensburg, a municipal corporation of the State of Washington for the pooling of funds received by the City of Ellensburg pursuant to its execution of the One Washington Memorandum of Understanding with those received by Kittitas County. WHEREAS, the parties are public agencies as defined in the lnterlocal Cooperation Act (RCW 39.341, and wish to enter into this Agreement pursuant to the provisions of said Act, which allows public agencies to cooperate on a basis of mutual advantage to provide services and facilities in an optimized manner to address the needs of local communities; and WHEREAS, the people of the State of Washington have been harmed by entities within the pharmaceutical supply chain who manufacture, distribute and dispense prescription opioids; and WHEREAS, Washington State and certain local governments have and may continue to engage in litigation against entities within the pharmaceutical supply chain for their roles in the State's opioid epidemic resulting in large opioid distributors paying the State to end the litigation over multiple settlement agreements; a nd WHEREAS, the governing body of each party to this Agreement has approved such party's involvement in the cooperative interlocal activities as described herein; and WHEREAS, Kittitas County and the City of Ellensburg are participating local governments who have executed both the One Washington Memorandum of Understanding (MOU) Between Washington Municipalities and the Memorandum of Understanding between the Greater Columbia Region Municipalities to Establish an Opioid Abatement Council to establish a framework for the distribution and oversight of Opioid Funds (as that term is defined in both such agreements); and WHEREAS, Iocal governments that are parties to those agreements maintain full discretion over the use and distribution of their allocation of Opioid Funds, provided only L0% of those funds may be used for administrative costs and the balance must be used solely for Approved Purposes as that term is defined in the One Washington MOU; and WHEREAS, the City of Ellensburg desires to pool the Opioid Settlement Funds it receives pursuant to the above referenced MOUs with Kittitas County in order to best serve the residents of Ellensburg and Kittitas County; and WHEREAS; it is mutually beneficial for the parties to enter into this Agreement at this time; NOW, THEREFORE, Kittitas County and the City of Ellensburg hereby agree as follows: 1-. Purpose. The purpose of this Agreement is to effectively poolOpioid Settlement Funds to increase the benefit of opioid abatement strategies to the citizens of Ellensburg and Kittitas County. 2. Term. The term of this Agreement shall be from the last date of signature until the City of Ellensburg no longer receives Opioid Funds pursuant to the One Washington MOU and the Greater Columbia Region Opioid Abatement Council MOU, unless the Agreement is terminated early or its term is extended as provided herein. 3. Responsibilities of the Parties. a. Kittitas Countv's Responsibilities: i.Kittitas County agrees to designate a set amount of Opioid Funds available from their settlement account for each funding cycle. This set amount may be the same or differ from the amount set by the City of Ellensburg. Kittitas County will provide staff support to create, implement, and oversee a public request for proposal process to elicit project and activity proposals. Once each party has set an amount of available Opioid Funds, Kittitas County will select three staff to participate in the Opioid Settlement review group to score funding applications using an agreed upon scoring matrix and recommend projects and activities for approval by the legislative authorities for each Party. Staff may not represent departments or divisions applying for funding. At the time in which funding awards have been approved by the respective legislative authorities, Kittitas County agrees to accept the designated Opioid Funds from the City of Ellensburg and utilize them to pay for eligible projects and activities approved for funding. Kittitas County shall provide contract oversight, including invoicing and monitoring of deliverables, of allfunding awards using pooled Opioid Settlement funds. lt. ilt. tv Kittitas County will provide regular status reports and fiscal updates to the City of Ellensburg on the progress of funding recipients and will provide ad hoc updates to the City of Ellensburg as requested. Kittitas County shall receive and retain the City of Ellensburg's portion of Opioid Funds that may be allocated for administrative costs (1-0% of total). Kittitas County agrees to submit all reporting required by the regional Opioid Abatement Council (OAC) showing how the City of Ellensburg's forwarded funds have been expended on behalf of the City of Ellensburg. Kittitas County will provide copies of the filed reports to the City of Ellensburg after they have been accepted by the regional Opioid Abatement Council. Kittitas County agrees to hold 10% of funds for transfer to the OAC as required per the oAc Mou. Kittitas County agrees to pay up to L0% of OAC funds held to the OAC on behalf of both Kittitas County and the City of Ellensburg upon invoicing from the OAC. Any City of Ellensburg funds from a designated funding cycle that remain unspent (community awards or OAC hold) will be retained by Kittitas County for the sole purpose of being applied to the subsequent funding cycle. lf the unspent funds are from the final funding cycle, Kittitas County will provide these funds back to the City of Ellensburg at their request. b. Citv of Ellensburs's Responsibilities: V VI IX. x vil. vilt. il. ilt. iv The City of Ellensburg agrees to designate a set amount of Opioid Funds available from their settlement account for each funding cycle. This set amount may be the same or differ from the amount set by Kittitas County. The City of Ellensburg also agrees to designate an additional 10% (based on the amount set by the City of Ellensburg) to be held by Kittitas County for payment to the OAC. Once each party has set an amount of available Opioid Funds, the City of Ellensburg will select two staff to participate in the Opioid Settlement review group to score and recommend projects and activities for approval by the legislative authorities for each Party. Staff may not represent departments or divisions applying for funding. At the time in which funding awards have been approved by the respective legislative authorities, the City of Ellensburg agrees to promptly provide the County with the full designated amount of funds for that funding cycle. The City of Ellensburg shall notify the regional Opioid Abatement Council, in writing, that their Opioid Funds will be transferred to Kittitas County. c.Joint Responsibilities of the Parties ilt. Both parties will ensure that all requirements of the One Washington MOU found in Exhibit A of this agreement and the Greater Columbia Opioid Abatement Council MOU found in Exhibit B of this agreement specific to each individual entity are met. Both parties agree to support the funding priorities established by the community-based input of the Community Health lmprovement Plan and One Washington MOU Opioid Abatement Strategies Crosswalk Analysis, found in Exhibit C of this agreement. Both parties agree to fund the Kittitas County Public Health Department Harm Reduction Program outside of the public request for proposals process in the total amount of 5100,000 per year for five years beginning January L,2O25. fhe City of Ellensburg will contribute 510,000 each year, and Kittitas County will contribute 590,000 each year. The Harm Reduction program meets funding priorities and is recognized by both parties as a critical prevention and response support to residents of the City of Ellensburg and Kittitas County. Both parties will coordinate the timely presentation of funding recommendations to their respective legislative authorities for final approval. No funds will be granted until approvalfrom both parties has been granted via resolutions by the respective legislative authorities. lf a legislative authority chooses to deny a funding recommendation, no joint funding will be provided to that applicant. However, each party retains the right to provide separate funding to applicants, outside of this Agreement. Both parties will work collaboratively to share results and outcomes of funding awards publicly. 4. Points ofContact. The parties' addresses and points of contact for any notices to be delivered under this Agreement are as follows: KITTITAS COUNTY CITY OF ELLENSBURG il. IV v. 205 West 5th Ave, Suite 108 Ellensburg, WA 98926 Kasey Knutson Human Services Manager Kittitas County Public Health Department 509-962-7515 kasey. knutson @co. kittitas.wa. us 50L N Anderson Ellensburg, WA 98926 Heidi Behrends Cerniwey City Manager City Manager's Office 509-962-722L ce rn iweyh @e I le ns bu rgwa. gov 5. Disbursement of Funds to Elisible Proiects. Projects selected for funding will contract directly with Kittitas County. All invoiced expenses will be reviewed by Kittitas County for allowability, and any expenses found to be unallowable will be denied. Allfunded projects will be required to submit progress reports and updates on achievement of goals and deliverables. 5. Budeet and Pavment. Settlement funds will be disbursed in several phases, based on availability of funds. At such a point when both parties determine sufficient settlement funds have been received, a Request for Proposals (RFP) will be released to the community. The RFP will have a set maximum amount to be distributed to be determined by settlement funds received and in the possession of each party. Both parties will agree to the total amount available for the phase. Kittitas County will provide staff support to administer the RFP. Once proposals have been reviewed for eligibility and scored by the Opioid Settlement Review group, the group will vote on proposals to recommend for funding and will create formal recommendations based on majority vote. Once each party's legislative body has approved funding proposals for execution, Kittitas County will invoice the City of Ellensburg for the total agreed upon amount for the entire disbursement phase. Kittitas County willthen administer funds to the selected agencies through monthly reimbursement of allowable costs incurred. 7. Administration. For the purposes of RCW 39.34.030(4)(a), the points of contact as listed in section 4. above shall be the administrators of this Agreement. No separate legal or administrative entity is created by this Agreement. No joint budget or financing method is created by this Agreement; each party will manage its own financing and budgeting processes hereunder. This Agreement will be posted online or filed with the county auditor as required by RCW 39.34.040. 8. Termination. This Agreement may be terminated at any time by mutual written agreement of the parties. Additionally, this Agreement may be terminated unilaterally at any time by either party with thirty (30) days' written notice to the other party. Termination of this Agreement by any means provided herein shall not excuse either party's performance of its obligations hereunder through the effective date of termination. 9. Modification. The parties may modify the terms of this Agreement through one or more formal written amendments, signed by both parties. 10. Notices. Written notices required or permitted to be provided by one party to the other party under this Agreement may be provided by personal delivery, legal courier service, or certified mail, postage prepaid and return receipt requested. Notice may be provided by regular first class mail if simultaneous notice is provided by email. Notices given by a party shall be provided to the other party's point of contact as listed in Section 4. of this Agreement. 11. lnsurance. Each party shall maintain general liability coverage at all times, and such liability coverage documents shall be made available to the other party on an annual basis. Each party may choose to share the other party's coverage documents with their insurance carrier or risk pool. The failure of any insurance carrier or self-insured pooling organization to agree to or follow the terms of this section shall not relieve any individual party from its obligations under this Agreement. 12. Propertv. The parties do not anticipate acquiring jointly owned personal or real propefi under this Agreement. Any personal property of a party used in the performance of this Agreement in the possession of the other party shall be returned to the owner promptly upon completion of each task for which such personal property was utilized. 13. Records. Each party shall preserve and maintain its records relating to this Agreement for six (6) years after termination or expiration of the Agreement. Such records shall be subject to inspection, review and audit by either party, the Washington State Auditor's Office, or any other entity as required by law. 14. lndemnification. Each party will be responsible for its own acts and/or omissions in its performance under this Agreement, and the acts and/or omissions of its employees, agents, officials, and registered volunteers. Neither party shall be responsible to the other party for the acts or omissions of persons or entities not a party to this Agreement. The parties agree to maintain a consolidated defense to claims made against them and to reserve all indemnity claims against each other until after liability to the claimant and damages, if any, are adjudicated. lf any claim is resolved by voluntary settlement and the parties cannot agree upon apportionment of damages and defense costs, they shall submit apportionment to binding arbitration. The indemnification obligations of the parties shall not be limited in any way by the Washington State lndustrial lnsurance Act, RCW Title 51, or by application of any other workmen's compensation act, disability benefit act or other employee benefit act. Each party hereby expressly waives any immunity afforded by such acts to the extent required by its obligations to indemnify, defend and h6ld harmless the other party. A party's waiver of immunity does not extend to claims made by its employees directly against the party as employer. The foregoing indemnification obligations of the parties are a material inducement to enter into this Agreement and have been mutually negotiated. 15. lndependent Capacitv. Each party to this Agreement shall act in an independent capacity and not as an agent or representative of the other party. The employees or agents of each party who are engaged in the performance of this Agreement shall continue to be the employees or agents ofthat party, and shall not be considered for any purpose to be the employees or agents of the other party. 16. Severabilitv. lf any provision of this Agreement shall be held invalid, such invalidity shall not affect the other provisions of this Agreement that can be given effect without the invalid provision, if such remainder is consistent with applicable law and with the fundamental purpose of this Agreement, and to this end the provisions of this Agreement are declared to be severable. 17. Waiver. The waiver by a party of any default or breach of this Agreement, or the failure of a party to enforce any provision hereof or to exercise any right or privilege hereunder, shall not be deemed to waive any prior or subsequent breach or default, the enforcement of any provision hereof, or the exercise of any right or privilege hereunder, unless othenruise stated in a signed writing by the party granting such waiver. 18. Disputes. ln the event of a dispute between the parties relating to this Agreement, the parties agree to make a good faith attempt to resolve such dispute informally, prior to the commencement of any legal action or arbitration. 19. Governins Law. This Agreement shall be governed by the laws of the State of Washington. 20. Force Maieure. ln the event of a forced delay in performance by a party of its obligations under this Agreement, due to causes beyond that party's reasonable control, including but not limited to natural disasters, epidemics, embargoes, war, insurrection, riots, or strikes, such party's time for performance under this Agreement shall be extended for the period of the forced delay. 21. Entire Asreement. This Agreement constitutes the entire agreement between the parties and supersedes any and all other agreements, understandings, negotiations and discussions, oral or written, express or implied, relating to the subject matter hereof. lN WITNESS WHEREOF, this Agreement has been executed by and on behalf of the parties through their authorized representatives, effective as of the latest date written below. KITTITAS COUNTY MISSIONERS ABSENT Vice-Chair m CITY OF EIIENSB City Manager re Printed Name Title SEAI Attest: Date Date: EXHIBITA ONE WASHINGTON MEMORANDIUM OF UNDERSTANDING BETWEEN WASHINGTON MUNICIPALITIES ONE WASIIINGTON MEMORANDUM OF UNDERSTANDING BETWEEN WASHINGTON MUNICIPALITIES Whereas, the people of the State of Washington and its communities have been harmed by entities within the Pharmaceutical Supply Chain who manufacture, distribute, and dispense prescription opioids; Whereas, certain Local Governments, through their elected representatives and counsel, are engaged in litigation seeking to hold these entities within the Pharmaceutical Supply Chain of prescription opioids accountable for the damage they have caused to the Local Governments; Whereas, Local Governments and elected officials share a common desire to abate and alleviate the impacts of harms caused by these entities within the Pharmaceutical Supply Chain throughout the State of Washington, and strive to ensure that principals of equity and equitable service delivery are factors considered in the allocation and use of Opioid Funds; and Whereas, certain Local Governments engaged in litigation and the other cities and counties in Washington desire to agree on a form of allocation for Opioid Funds they receive from entities within the Pharmaceutical Supply Chain. Now therefore, the Local Governments enter into this Memorandum of Understanding ("MOU") relating to the allocation and use of the proceeds of Settlements described. A. Definitions As used in this MOU: l. "Allocation Regions" are the same geographic areas as the existing nine (9) Washington State Accountable Community of Health (ACH) Regions and have the purpose described in Section C below. 2. "Approved Purpose(s)" shall mean the strategies specified and set forth in the Opioid Abatement Strategies attached as Exhibit A. 3. "Effective Date" shall mean the date on which a court of competent jurisdiction enters the first Settlement by order or consent decree. The Parties anticipate that more than one Settlement will be administered according to the terms of this MOU, but that the first entered Settlement will trigger allocation of Opioid Funds in accordance with Section B herein, and the formation of the Opioid Abatement Councils in Section C. 4. "Litigatinglocal Government(s)" shall mean Local Governments that filed suit against any Pharmaceutical Supply Chain Participant pertaining to the Opioid epidemic prior to September 1,2020. L 5. "Local Government(s)" shall mean all counties, cities, and towns within the geographic boundaries of the State of Washington. 6. 'National Settlement Agreements" means the national opioid settlement agreements dated July 2I,2021involving Johnson & Johnson, and distributors AmerisourceBergen, Cardinal Health and McKesson as well as their subsidiaries, affiliates, officers, and directors named in the National Settlement Agreements, including all amendments thereto. 7. "Opioid Funds" shall mean monetary amounts obtained through a Settlement as defined in this MOU. 8. "Opioid Abatement Council" shall have the meaning described in Section C below. 9. "Participating Local Government(s)" shall mean all counties, cities, and towns within the geographic boundaries of the State that have chosen to sign on to this MOU. The Participating Local Governments may be referred to separately in this MOU as "Participating Counties" and "Participating Cities and Towns" (or "Participating Cities or Towns," as appropriate) or "Parties." 10. "Pharmaceutical Supply Chain" shall mean the process and channels through which controlled substances are manufactured, marketed, promoted, distributed, and/or dispensed, including prescription opioids. 11. "Pharmaceutical Supply Chain Participant" shall mean any entity that engages in or has engaged in the manufacture, marketing, promotion, distribution, and/or dispensing of a prescription opioid, including any entity that has assisted in any ofthe above. 12. "Qualified Settlement Fund Account," or "QSF Account," shall mean an account set up as a qualified settlement fund, 468b fund, as authorized by Treasury Regulations 1.a68B-l(c) (26 CFR $1.4688-1). 13. "Regional Agreements" shall mean the understanding reached by the Participating Local Counties and Cities within an Allocation Region governing the allocation, management, distribution of Opioid Funds within that Allocation Region. 14. "Settlement" shall mean the future negotiated resolution of legal or equitable claims against a Pharmaceutical Supply Chain Participant when that resolution has been jointly entered into by the Participating Local Governments. "Settlement" expressly does not include a plan of reorganization confirmed under Title I lof the United States Code, irrespective of the extent to which Participating Local Governments vote in favor of or otherwise support such plan of reorganization. 2 15. "Trustee" shall mean an independent trustee who shall be responsible for the ministerial task of releasing Opioid Funds from a QSF account to Participating Local Governments as authorized herein and accounting for all payments into or out of the trust. 16. The "Washington State Accountable Communities of Health" or 66ACH" shall mean the nine (9) regions described in Section C below. B. Allocation of Settlement Proceeds for Approved Purposes 1. All Opioid Funds shall be held in a QSF and distributed by the Trustee, for the benefit of the Participating Local Governments, only in a manner consistent with this MOU. Distribution of Opioid Funds will be subject to the mechanisms for auditing and reporting set forth below to provide public accountability and transparency. 2. All Opioid Funds, regardless of allocation, shall be utilized pursuant to Approved Purposes as defined herein and set fonh in Exhibit A. Compliance with this requirement shall be verified through reporting, as set out in this MOU. 3. The division of Opioid Funds shall frst be allocated to Participating Counties based on the methodology utilized for the Negotiation Class in In Re: National Prescription Opiate Litigation, United States District Court for the Northern District of Ohio, Case No. l:17-md-02804-DAP. The allocation model uses three equally weighted factors: (1) the amount of opioids shipped to the county; (2) the number of opioid deaths that occurred in that county; and (3) the number of people who suffer opioid use disorder in that county. The allocation percentages that result from application of this methodology are set forth in the "County Total" line item in Exhibit B. In the event any county does not participate in this MOU, that county's percentage share shall be reallocated proportionally amongst the Participating Counties by applying this same methodology to only the Participating Counties. 4. Allocation and distribution of Opioid Funds within each Participating County will be based on regional agreements as described in Section C. C. Regional Agreements 1. For the purpose of this MOU, the regional structure for decision- making related to opioid fund allocation will be based upon the nine (9) pre- defined Washington State Accountable Community of Health Regions (Allocation Regions). Reference to these pre-defined regions is solely for the purpose of 3 a a a a a a a drawing geographic boundaries to facilitate regional agreements for use of Opioid Funds. The Allocation Regions are as follows: King County (Single County Region) Pierce County (Single County Region) Olympic Community of Health Region (Clallam, Jefferson, and Kitsap Counties) Cbscade Pacific Action Alliance Region (Cowlitz, Grays Harbor, Lewis, Mason, Pacific, Thurston, and Wahkiakum Counties) North Sound Region (Island, San Juan, Skagit, Snohomish, and Whatcom Counties) SouthWest Region (Clark, Klickitat, and Skamania Counties) Greater Columbia Region (Asotin, Benton, Columbia, Franklin, Garfield, Kittitas, Walla Walla, Whitman, and Yakima Counties) Spokane Region (Adams, Ferry, Lincoln, Pend Oreille, Spokane, and Stevens Counties) North Central Region (Chelan, Douglas, Grant, and Okanogan Counties) 2. Opioid Funds will be allocated, distributed and managed within each Allocation Region, as determined by its Regional Agreement as set forth below. If an Allocation Region does not have a Regional Agreement enumerated in this MOU, and does not subsequently adopt a Regional Agreement per Section C.5, the default mechanism for allocation, distribution and management of Opioid Funds described in Section C.4.a will apply. Each Allocation Region must have an OAC whose composition and responsibilities shall be defined by Regional Agreement or as set forth in Section C.4. 3. King County's Regional Agreement is reflected in Exhibit C to this MOU 4. All other Allocation Regions that have not specified a Regional Agreement for allocating, distributing and managing Opioid Funds, will apply the following default methodology: a. Opioid Funds shall be allocated within each Allocation Region by taking the allocation for a Participating County from Exhibit B and apportioning those funds between that Participating County and its Participating Cities and Towns. Exhibit B also sets forth the allocation to the Participating Counties and the Participating Cities or Towns within the Counties based on a default allocation formula. As set forth above in Section B.3, to determine the allocation to a county, this formula utilizes: (1) the amount of opioids shipped to the county; (2) the number of opioid deaths that occurred in that county; and (3) the number of people who suffer opioid use disorder in that county. To determine the allocation within a county, the formula utilizes historical federal data showing how the specific Counties and the Cities and Towns within the Counties have a 4 made opioids epidemic-related expenditures in the past. This is the same methodology used in the National Settlement Agreements for county and intra-county allocations. A Participating County, and the Cities and Towns within it may enter into a separate intra-county allocation agreement to modify how the Opioid Funds are allocated amongst themselves, provided the modification is in writing and agreed to by all Participating Local Governments in the County. Such an agreement shall not modifu any of the other terms or requirements of this MOU. b. 10% of the Opioid Funds received by the Region will be reserved, on an annual basis, for administrative costs related to the OAC. The OAC will provide an annual accounting for actual costs and any reserved funds that exceed actual costs will be reallocated to Participating Local Governments within the Region. c. Cities and towns with a population of less than 10,000 shall be excluded from the allocation, with the exception of cities and towns that are Litigating Participating Local Governments. The portion of the Opioid Funds that would have been allocated to a city or town with a population of less than 10,000 that is not a Litigating Participating Local Government shall be redistributed to Participating Counties in the manner directed in C.4.a above. d. Each Participating County, City, or Town may elect to have its share re-allocated to the OAC in which it is located. The OAC will then utilize this share for the benefit of Participating Local Governments within that Allocation Region, consistent with the Approved Purposes set forth in Exhibit A. A Participating Local Government's election to forego its allocation of Opioid Funds shall apply to all future allocations unless the Participating Local Government notifies its respective OAC otherwise. If a Participating Local Government elects to forego its allocation of the Opioid Funds, the Participating Local Government shall be excused from the reporting requirements set forth in this Agreement. e. Participating Local Governments that receive a direct payment maintain full discretion over the use and distribution of their allocation of Opioid Funds, provided the Opioid Funds are used solely for Approved Purposes. Reasonable administrative costs for a Participating Local Government to administer its allocation of Opioid Funds shall not exceed actual costs or l0% of the Participating Local Government's allocation of Opioid Funds, whichever is less. f. A Local Government that chooses not to become a Participating Local Government will not receive a direct allocation of Opioid Funds. The portion of the Opioid Funds that would have been allocated to a Local Government that is not a Participating Local Government shall be 5 redistributed to Participating Counties in the manner directed in C.4.a above. g. As a condition of receiving a direct payment, each Participating Local Government that receives a direct payment agrees to undertake the following actions: Developing a methodology for obtaining proposals for use of Opioid Funds. Ensuring there is opportunity for community-based input on priorities for Opioid Fund programs and services. Receiving and reviewing proposals for use of Opioid Funds for Approved Purposes. Approving or denying proposals for use of Opioid Funds for Approved Purposes. Receiving funds from the Trustee for approved proposals and distributing the Opioid Funds to the recipient. Reporting to the OAC and making publicly available all decisions on Opioid Fund allocation applications, distributions and expenditures. h. Prior to any distribution of Opioid Funds within the Allocation Region, The Participating Local Governments must establish an Opioid Abatement Council (OAC) to oversee Opioid Fund allocation, distribution, expenditures and dispute resolution. The OAC may be a preexisting regional body or may be a new body created for purposes of executing the obligations of this MOU. i. The OAC for each Allocation Region shall be composed of representation from both Participating Counties and Participating Towns or Cities within the Region. The method of selecting members, and the terms for which they will serve will be determined by the Allocation Region's Participating Local Governments. All persons who serve on the OAC must have work or educational experience pertaining to one or more Approved Uses. j. The Regional OAC will be responsible for the following actions: Overseeing distribution of Opioid Funds from Participating Local Governments to programs and services within the Allocation Region for Approved Purposes. l. ii. iii. iv. v v1. 6 ll.Annual review of expenditure reports from Participating Local Jurisdictions within the Allocation Region for compliance with Approved Purposes and the terms of this MOU and any Settlement. In the case where Participating Local Governments chose to forego their allocation of Opioid Funds: (i) Approving or denying proposals by Participating Local Governments or community groups to the OAC for use of Opioid Funds within the Allocation Region. (ii) Directing the Trustee to distribute Opioid Funds for use by Participating Local Governments or community groups whose proposals are approved by the OAC. (iii) Administrating and maintaining records of all OAC decisions and distributions of Opioid Funds. Reporting and making publicly available all decisions on Opioid Fund allocation applications, distributions and expenditures by the OAC or directly by Participating Local Governments. Developing and maintaining a centralized public dashboard or other repository for the publication of expenditure data from any Participating Local Government that receives Opioid Funds, and for expenditures by the OAC in that Allocation Region, which it shall update at least annually. lf necessary, requiring and collecting additional outcome- related data from Participating Local Governments to evaluate the use of Opioid Funds, and all Participating Local Governments shall comply with such requirements. Hearing complaints by Participating Local Governments within the Allocation Region regarding alleged failure to (1) use Opioid Funds for Approved Purposes or (2) comply with reporting requirements. lll. vl. vll lv v 5. Participating Local Governments may agree and elect to share, pool, or collaborate with their respective allocation of Opioid Funds in any manner they choose by adopting a Regional Agreement, so long as such sharing, pooling, or collaboration is used for Approved Purposes and complies with the terms of this MOU and any Settlement. 7 6. Nothing in this MOU should alter or change any Participating Local Government's rights to pursue its own claim. Rather, the intent of this MOU is to join all parties who wish to be Participating Local Governments to agree upon an allocation formula for any Opioid Funds from any future binding Settlement with one or more Pharmaceutical Supply Chain Participants for all Local Governments in the State of Washington. 7. If any Participating Local Government disputes the amount it receives from its allocation of Opioid Funds, the Participating Local Government shall alert its respective OAC within sixty (60) days of discovering the information underlying the dispute. Failure to alert its OAC within this time frame shall not constitute a waiver of the Participating Local Government's right to seek recoupment of any deficiency in its allocation of Opioid Funds. 8. If any OAC concludes that a Participating Local Government's expenditure of its allocation of Opioid Funds did not comply with the Approved Purposes listed in Exhibit A, or the terms of this MOU, or that the Participating Local Government otherwise misused its allocation of Opioid Funds, the OAC may take remedial action against the alleged offending Participating Local Government. Such remedial action is left to the discretion ofthe OAC and may include withholding future Opioid Funds owed to the offending Participating Local Government or requiring the offending Participating Local Government to reimburse improperly expended Opioid Funds back to the OAC to be re-allocated to the remaining Participating Local Governments within that Region. 9. All Participating Local Governments and OAC shall maintain all records related to the receipt and expenditure of Opioid Funds for no less than five (5) years and shall make such records available for review by any other Participating Local Government or OAC, or the public. Records requested by the public shall be produced in accordance with Washington's Public Records Act RCW 42.56.001 et seq. Records requested by another Participating Local Government or an OAC shall be produced within twenty-one (21) days of the date the record request was received. This requirement does not supplant any Participating Local Government or OAC's obligations under Washington's Public Records Act RCW 42.56.001 et seq. D. Payment of Counsel and Litigation Expenses l. The Litigating Local Governments have incurred attorneys' fees and litigation expenses relating to their prosecution of claims against the Pharmaceutical Supply Chain Participants, and this prosecution has inured to the benefit of all Participating Local Governments. Accordingly, a Washington 8 Government Fee Fund ("GFF") shall be established that ensures that all Parties that receive Opioid Funds contribute to the payment of fees and expenses incurred to prosecute the claims against the Pharmaceutical Supply Chain Participants, regardless of whether they are litigating or non-litigating entities. 2. The amount of the GFF shall be based as follows: the funds to be deposited in the GFF shall be equal to l5%o of the total cash value of the Opioid Funds. 3. The maximum percentage of any contingency fee agreement permitted for compensation shall be 15% of the portion ofthe Opioid Funds allocated to the Litigating Local Government that is a pa(1 to the contingency fee agreement, plus expenses attributable to that Litigating Local Government. Under no circumstances may counsel collect more for its work on behalf of a Litigating Local Government than it would under its contingency agreement with that Litigating Local Government. 4. Payments from the GFF shall be overseen by a committee (the "Opioid Fee and Expense Committee") consisting of one representative of the following law firms: (a) Keller Rohrback L.LP.; (b) Hagens Berman Sobol Shapiro LLP; (c) Goldfarb & Huck Roth Riojas, PLLC; and (d) Napoli Shkolnik PLLC. The role of the Opioid Fee and Expense Committee shall be limited to ensuring that the GFF is administered in accordance with this Section. 5. In the event that settling Pharmaceutical Supply Chain Participants do not pay the fees and expenses of the Participating Local Governments directly at the time settlement is achieved, payments to counsel for Participating Local Governments shall be made from the GFF over not more than three years, with 50%o paid within l2 months of the date of Settlement and25Yo paid in each subsequent year, or at the time the total Sefflement amount is paid to the Trustee by the Defendants, whichever is sooner. 6. Any funds remaining in the GFF in excess of: (i) the amounts needed to cover Litigating Local Governments' private counsel's representation agreements, and (ii) the amounts needed to cover the common benefit tax discussed in Section C.8 below (if not paid directly by the Defendants in connection with future settlement(s), shall revert to the Participating Local Governments pro rata according to the percentages set forth in Exhibits B, to be used for Approved Purposes as set forth herein and in Exhibit A. 7. In the event that funds in the GFF are not sufficient to pay all fees and expenses owed under this Section, payments to counsel for all Litigating Local Governments shall be reduced on apro ratabasis. The Litigating Local Governments will not be responsible for any of these reduced amounts. 9 8. The Parties anticipate that any Opioid Funds they receive will be subject to a common benefit "tax" imposed by the court in In Re: National Prescription Opiate Litigation, United States District Court for the Northern District of Ohio, Case No. l:17-md-02804-DAP ("Common Benefit Tax"). If this occurs, the Participating Local Governments shall first seek to have the settling defendants pay the Common Benefit Tax. If the settling defendants do not agree to pay the Common Benefit Tax, then the Common Benefit Tax shall be paid from the Opioid Funds and by both litigating and non-litigating Local Governments. This payment shall occur prior to allocation and distribution of funds to the Participating Local Governments. In the event that GFF is not fully exhausted to pay the Litigating Local Governments' private counsel's representation agreements, excess funds in the GFF shall be applied to pay the Common Benefit Tax (if any). E. General Terms 1. If any Participating Local Government believes another Participating Local Government, not including the Regional Abatement Advisory Councils, violated the terms of this MOU, the alleging Participating Local Governmentmay seek to enforce the terms of this MOU in the court in which any applicable Settlement(s) was entered, provided the alleging Participating Local Government first provides the alleged offending Participating Local Government notice of the alleged violation(s) and a reasonable opportunity to cure the alleged violation(s). In such an enforcement action, any alleging Participating Local Government or alleged offending Participating Local Government may be represented by their respective public entity in accordance with Washington law. 2. Nothing in this MOU shall be interpreted to waive the right of any Participating Local Government to seekjudicial relief for conduct occurring outside the scope of this MOU that violates any Washington law. In such an action, the alleged offending Participating Local Government, including the Regional Abatement Advisory Councils, may be represented by their respective public entities in accordance with Washington law. In the event of a conflict, any Participating Local Government, including the Regional Abatement Advisory Councils and its Members, may seek outside representation to defend itself against such an action. 3. Venue for any legal action related to this MOU shall be in the court in which the Participating Local Government is located or in accordance with the court rules on venue in that jurisdiction. This provision is not intended to expand the court rules on venue. 4. This MOU may be executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. The Participating Local Governments approve the use of electronic signatures for execution of this MOU. All use of electronic signatures 10 shall be governed by the Uniform Electronic Transactions Act. The Parties agree not to deny the legal effect or enforceability of the MOU solely because it is in electronic form or because an electronic record was used in its formation. The Participating Local Government agree not to object to the admissibility of the MOU in the form of an electronic record, or a paper copy of an electronic document, or a paper copy of a document bearing an electronic signature, on the grounds that it is an electronic record or electronic signature or that it is not in its original form or is not an original. 5. Each Participating Local Government represents that all procedures necessary to authorize such Participating Local Government's execution of this MOU have been performed and that the person signing for such Party has been authorized to execute the MOU. [Remainder of Page Intentionally Left Blank- Signature Pages Follow] 7t This One Washington Memorandum of Understanding Between Washington Municipalities is signed this _ day of 2O22byz Name & Title On behalf of 4894-0031-1574, v. 2 L2 t! Xl+lllr -w -Fl OPIOID ABATEMENT STRATEGIBS PART ONE: TREATMENT A. TREAT OPIOID USE DISORDER (OUD) Support treatment of Opioid Use Disorder (O[ID) and any co-occurring Substance Use Disorder or Mental Health (SUD/I\4H) conditions, co-usage, and/or co-addiction through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 1. Expand availability of treatment for OUD and any co-occurring SUD/I\IH conditions, co-usage, and/or co-addiction, including all forms of Medication-Assisted Treatment (MAT) approved by the U.S. Food and Drug Administration. 2. Support and reimburse services that include the full American Society of Addiction Medicine (ASAM) continuum of care for OUD and any co-occurring SUD/IVIH conditions, co-usage, and/or co-addiction, including but not limited to: a. Medication-Assisted Treatment (MAT); b. Abstinence-based treatment; c. Treatment, recovery, or other services provided by states, subdivisions, community health centers; non-for-profit providers; or for-profit providers; d. Treatment by providers that focus on OUD treatment as well as treatment by providers that offer OUD treatment along with treatment for other SUDAvIH conditions, co-usage, and/or co-addiction; or e. Evidence-informed residential services programs, as noted below. 3. Expand telehealth to increase access to treatment for OUD and any co-occurring SUDIN{H conditions, co-usage, and/or co-addiction, including MAT, as well as counseling, psychiatric support, and other treatment and recovery support services. 4. Improve oversight of Opioid Treatment hograms (OTPs) to assure evidence-based, evidence-informed, or promising practices such as adequate methadone dosing. 5. Support mobile intervention, treatment, and recovery services, offered by qualified professionals and service providers, such as peer recovery coaches, for persons with OUD and any co-occuning SUD/IMH conditions, co-usage, and/or co-addiction and for persons who have experienced an opioid overdose. 6. Support treatment of mental health trauma resulting from the traumatic experiences of the opioid user (e.g., violence, sexual assault, human trafficking, or adverse childhood experiences) and family members (e.g., surviving family members after an overdose I or overdose fatality), and training ofhealth care personnel to identiff and address such trauma. 7. Support detoxification (detox) and withdrawal management services for persons with OUD and any co-occurring SUDA4H conditions, co-usage, and/or co-addiction, including medical detox, referral to treatment, or connections to other services or supports. 8. Support fraining on MAT for health care providers, students, or other supporting professionals, such as peer recovery coaches or recovery outreach specialists, including telementoring to assist community-based providers in rural or underserved areas 9. Support workforce development for addiction professionals who work with persons with OUD and any co-occurring SUD/IVIH conditions, co-usage, and/or co-addiction. 10. Provide fellowships for addiction medicine specialists for direct patient care, instructors, and clinical research for treatments. I l. Provide funding and training for clinicians to obtain a waiver under the federal Drug Addiction Treatment Act of 2000 (DATA 2000) to prescribe MAT for OUD, and provide technical assistance and professional support to clinicians who have obtained a DATA 2000 waiver. 12. Support the dissemination of web-based training curricul4 such as the American Academy of Addiction Psychiatry's Provider Clinical Support Service-Opioids web- based training curriculum and motivational interviewing. 13. Support the development and dissemination of new curricula, such as the American Academy of Addiction Psychiatry's Provider Clinical Support Service for Medication-Assi sted Treatment. B. SUPPORT PEOPLE IN TREATMENT AND RECOVERY Support people in treatment for and recovery from OUD and any co-occurring SUDIN4H conditions, co-usage? and/or co-addiction through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 1. Provide the full continuum of care of recovery services for OUD and any co-occurring SUDA4H conditions, co-usage, and/or co-addiction, including supportive housing, residential treatment, medical detox services, peer support services and counseling, community navigators, case management, and connections to community-based services. 2. Provide counseling, peer-support, recovery case management and residential treatment with access to medications for those who need it to persons with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction. 2 3. Provide access to housing for people with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction, including supportive housing, recovery housing, housing assistance programs, or training for housing providers. 4. Provide community support services, including social and legal services, to assist in deinstitutionalizingpersons with OUD and any co-occurring SUD/IVIH conditions, co- usage, and/or co-addiction. 5. Support or expand peer-recovery centers, which may include support groups, social events, computer access, or other services for persons with OUD and any co-occurring SUD/IVIH conditions, co-usage, and/or co-addiction. 6. Provide employment training or educational services for persons in treatment for or recovery from OUD and any co-occurring SUD/I\4H conditions, co-usage, and/or co- addiction. 7. Identif successful recovery programs such as physician, pilot, and college recovery programs, and provide support and technical assistance to increase the number and capacity of high-quality programs to help those in recovery. 8. Engage non-profits, faith-based communities, and community coalitions to support people in ffeatment and recovery and to support family members in their efforts to manage the opioid user in the family. 9. Provide training and development of procedures for government staff to appropriately interact and provide social and other services to current and recovering opioid users, including reducing stigma. 10. Support stigma reduction efforts regarding treatment and support for persons with OUD, including reducing the stigma on effective treatment. C. CONNECT PEOPLE WHO NEED HELP TO THE HELP THEY NEED (COIIIIECTIONS TO CARE) Provide connections to care for people who have - or are at risk of developing - OUD and any co-occurring SUD/IvIH conditions, co-usage, and/or co-addiction through evidence- based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 1. Ensure that health care providers are screening for OUD and other risk factors and know how to appropriately counsel and treat (or refer if necessary) a patient for OUD treatment. 2. Support Screening, Brief Intervention and Referral to Treatment (SBIRT) programs to reduce the transition from use to disorders. 3. Provide training and long-term implementation of SBIRT in key systems (health, schools, colleges, criminal justice, and probation), with a focus on youth and young adults when transition from misuse to opioid disorder is common. J 4. Purchase automated versions of SBIRT and support ongoing costs of the technology. 5. Support training for emergency room personnel treating opioid overdose patients on post-discharge planning, including community referrals for MAT, recovery case management or support services. 6. Support hospital programs that transition persons with OUD and any co-occurring SUDA4H conditions, co-usage, and/or co-addiction, or persons who have experienced an opioid overdose, into community treatment or recovery services through a bridge clinic or similar approach. 7 . Support crisis stabilization centers that serve as an alternative to hospital emergency departments for persons with OUD and any co-occurring SUDA4H conditions, co- usage, and/or co-addiction or persons that have experienced an opioid overdose. 8. Support the work of Emergency Medical Systems, including peer support specialists, to connect individuals to treatment or other appropriate services following an opioid overdose or other opioid-related adverse event. 9. Provide funding for peer support specialists or recovery coaches in emergency departments, detox facilities, recovery centers, recovery housing, or similar settings; offer services, supports, or connections to care to persons with OUD and any co- occurring SUDA4H conditions, co-usage, andlor co-addiction or to persons who have experienced an opioid overdose. 10. Provide funding for peer navigators, recovery coaches, care coordinators, or care managers that offer assistance to persons with OUD and any co-occurring SUD/I4H conditions, co-usage, and/or co-addiction or to persons who have experienced on opioid overdose. 1 1. Create or support school-based contacts that parents can engage with to seek immediate treatment services for their child; and support prevention, intervention, treatment, and recovery programs focused on young people. 12. Develop and support best practices on addressing OUD in the workplace. 13. Support assistance programs for health care providers with OUD. l4.Engage non-profits and the faith community as a system to support outreach for treatment. 15. Support centralized call centers that provide information and connections to appropriate services and supports for persons with OUD and any co-occurring SUD/IVIH conditions, co-usage, and/or co-addiction. 16. Create or support intake and call centers to facilitate education and access to treatment, prevention, and recovery services for persons with OUD and any co- occurring SUDAvIH conditions, co-usage, and/or co-addiction. 4 17. Develop or support a National Treatment Availability Clearinghouse a multistate/nationally accessible database whereby health care providers can list locations for currently available in-patient and out-patient OUD treatment services that are accessible on a real-time basis by persons who seek treatment. D. ADDRESS THE I\EEDS OF CRIMINAL-JUSTICE-INVOLVED PERSONS Address the needs of persons with OUD and any co-occurring SUD/IVfH conditions, co- usage, andlor co-addiction who are involved - or are at risk of becoming involved - in the criminal justice system through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 1. Support pre-arrest or post-arrest diversion and deflection strategies for persons with OUD and any co-occurring SUDA4H conditions, co-usage, and/or co-addiction, including established strategies such as: a. Self-referral strategies such as the Angel Programs or the Police Assisted Addiction Recovery lnitiative (PAARI); b. Active outreach strategies such as the Drug Abuse Response Team (DART) model; 'Naloxone Plus" strategies, which work to ensure that individuals who have received naloxone to reverse the effects of an overdose are then linked to treatment programs or other appropriate services; d. Officer prevention strategies, such as the Law Enforcement Assisted Diversion (LEAD) model; e. Officer intervention strategies such as the Leon County, Florida Adult Civil Citation Network or the Chicago Westside Narcotics Diversion to Treatment Initiative; f. Co-responder and/or alternative responder models to address OUD-related 911 calls with greater SUD expertise and to reduce perceived barriers associated with law enforcement 911 responses; or g. County prosecution diversion programs, including diversion officer salary, only for counties with a population of 50,000 or less. Any diversion services in matters involving opioids must include drug testing, monitoring, or treatment. 2. Support pre-trial services that connect individuals with OUD and any co-occurring SUD/IVIH conditions, co-usage, and/or co-addiction to evidence-informed treatment, including MAT, and related services. 3. Support treatment and recovery courts for persons with OUD and any co-occurring SUDA4H conditions, co-usage, and/or co-addiction, but only if these courts provide referrals to evidence-informed treatm ent, inc ludin g MAT. c 5 4. Provide evidence-informed treatment, including MAT, recovery support, or other appropriate services to individuals with OUD and any co-occurring SUDA4H conditions, co-usage, and/or co-addiction who are incarcerated in jail or prison. 5. Provide evidence-informed treatment, including MAT, recovery support, or other appropriate services to individuals with OUD and any co-occurring SUD/IVIH conditions, co-usage, and/or co-addiction who are leaving jail or prison have recently left jail or prison, are on probation or parole, are under community corrections supervision, or are in re-entry programs or facilities. 6. Support critical time interventions (CTI), particularly for individuals living with dual- diagnosis OUD/serious mental illness, and services for individuals who face immediate risks and service needs and risks upon release from correctional settings. 7. Provide training on best practices for addressing the needs of criminal-justice- involved persons with OUD and any co-occurring SUD/NIH conditions, co-usage, and/or co-addiction to law enforcement, correctional, or judicial personnel or to providers of treatment, recovery, case management, or other services offered in connection with any of the strategies described in this section. E. ADDRESS THE I\EEDS OF PREGNANT OR PARENTING WOMEN AND THEIR FAMILIES. INCLUDING BABIES WITH NEONATAL ABSTINENCE SYNDROME Address the needs of pregnant or parenting women with OUD and any co-occurring SUDA4H conditions, co-usage, and/or co-addiction, and the needs of their families, including babies with neonatal abstinence syndrome, through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 1. Support evidence-based, evidence-informed, or promising treatment, including MAT, recovery services and supports, and prevention services for pregnant women - or women who could become pregnant - who have OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction, and other measures to educate and provide support to families affected by Neonatal Abstinence Syndrome. 2. Provide training for obstetricians or other healthcare personnel that work with pregnant women and their families regarding treatment of OUD and any co-occurring SUDA4H conditions, co-usage, and/or co-addiction. 3. Provide training to health care providers who work with pregnant or parenting women on best practices for compliance with federal requirements that children born with Neonatal Abstinence Syndrome get referred to appropriate services and receive a plan of safe care. 4. Provide enhanced support for children and family members suffering trauma as a result of addiction in the family; and offer trauma-informed behavioral health treatment for adverse childhood events. 6 5. Offer enhanced family supports and home-based wrap-around services to persons with OUD and any co-occurring SUDA4H conditions, co-usage, and/or co-addiction, including but not limited to parent skills training. 6. Support for Children's Services - Fund additional positions and services, including supportive housing and other residential services, relating to children being removed from the home and/or placed in foster care due to custodial opioid use. PART TWO: PREVENTION F" PREVENT OVER-PRESCRIBING AI\D ENSURE APPROPRIATE PRESCRIBING AND DISPENSING OF OPIOIDS Support efforts to prevent over-prescribing and ensure appropriate prescribing and dispensing of opioids through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 1. Training for health care providers regarding safe and responsible opioid prescribing, dosing, and tapering patients off opioids. 2. Academic counter-detailing to educate prescribers on appropriate opioid prescribing. 3. Continuing Medical Education (CME) on appropriate prescribing of opioids. 4. Support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain. 5. Support enhancements or improvements to Prescription Drug Monitoring Programs (PDMPs), including but not limited to improvements that: a. Increase the number of prescribers using PDMPs; b. Improve point-of-care decision-making by increasing the quantity, quality, or format of data available to prescribers using PDMPs or by improving the interface that prescribers use to access PDMP data, or both; or c. Enable states to use PDMP data in support of surveillance or intervention strategies, including MAT referrals and follow-up for individuals identified within PDMP data as likely to experience OUD. 6. Development and implementation of a national PDMP - Fund development of a multistate/national PDMP that permits information sharing while providing appropriate safeguards on sharing of private health information, including but not limited to: a. Integration of PDMP data with electronic health records, overdose episodes, and decision support tools for health care providers relating to OUD. 7 b. Ensuring PDMPs incorporate available overdose/naloxone deployment data, including the United States Department of Transportation's Emergency Medical Technician overdose database. 7. Increase electronic prescribing to prevent diversion or forgery 8. Educate Dispensers on appropriate opioid dispensing. G. PREVENT MISUSE OF OPIOIDS Support efforts to discourage or prevent misuse of opioids through evidence-based, evidence- informed, or promising programs or strategies that may include, but are not limited to, the following: l. Corrective advertising or affirmative public education campaigns based on evidence. 2. Public education relating to drug disposal. 3. Drug take-back disposal or destruction programs. 4. Fund community anti-drug coalitions that engage in drug prevention effiorts. 5. Support community coalitions in implementing evidence-informed prevention, such as reduced social access and physical access, stigma reduction - including staffing, educational campaigns, support for people in treatment or recovery, or training of coalitions in evidence-informed implementation, including the Strategic Prevention Framework developed by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA). 6. Engage non-profits and faith-based communities as systems to support prevention. 7 - Support evidence-informed school and community education programs and campaigns for students, families, school employees, school athletic programs, parent- teacher and student associations, and others. 8. School-based or youth-focused programs or strategies that have demonstrated effectiveness in preventing drug misuse and seem likely to be effective in preventing the uptake and use of opioids. 9. Support community-based education or intervention services for families, youth, and adolescents at risk for OUD and any co-occurring SUD/IVIH conditions, co-usage, and/or co-addiction. 10. Support evidence-informed programs or curricula to address mental health needs of young people who may be at risk of misusing opioids or other drugs, including emotional modulation and resilience skills. 1 1. Support greater access to mental health services and supports for young people, including services and supports provided by school nurses or other school staff, to 8 address mental health needs in young people that (when not properly addressed) increase the risk of opioid or other drug misuse. H. PREVENT OVERDOSE DEATHS AND OTHERHARMS Support efforts to prevent or reduce overdose deaths or other opioid-related harms through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: l. Increase availability and distribution of naloxone and other drugs that treat overdoses for first responders, overdose patients, opioid users, families and friends of opioid users, schools, community navigators and outreach workers, drug offenders upon release from jaiVprison, or other members of the general public. 2. Provision by public health entities of free naloxone to anyone in the community, including but not limited to provision of intra-nasal naloxone in settings where other options are not available or allowed. 3. Training and education regarding naloxone and other drugs that treat overdoses for first responders, overdose patients, patients taking opioids, families, schools, and other members of the general public. 4. Enable school nurses and other school staff to respond to opioid overdoses, and provide them with naloxone, training, and support. 5. Expand, improve, or develop data tracking software and applications for overdoses/naloxone revivals. 6. Public education relating to emergency responses to overdoses. 7. Public education relating to immunity and Good Samaritan laws. 8. Educate first responders regarding the existence and operation of immunity and Good Samaritan laws. 9. Expand access to testing and treatment for infectious diseases such as HIV and Hepatitis C resulting from intravenous opioid use. 10. Support mobile units that offer or provide referrals to treatment, recovery supports, health care, or other appropriate services to persons that use opioids or persons with OUD and any co-occurring SUD/IVIH conditions, co-usage, and/or co-addiction. 1 1. Provide training in treatment and recovery strategies to health care providers, students, peer recovery coaches, recovery outreach specialists, or other professionals that provide care to persons who use opioids or persons with OUD and any co- occurring SUDA4H conditions, co-usage, and/or co-addiction. 12. Support screening for fentanyl in routine clinical toxicology testing. 9 PART THREE: OTHER STRATEGIES I. FIRST RESPONDERS In addition to items C8, Dl through D7,Hl, H3, and H8, support the following l. Current and future law enforcement expenditures relating to the opioid epidemic. 2. Educate law enforcement or other first responders regarding appropriate practices and precautions when dealing with fentanyl or other drugs. J. LEADERSHIP. PLANNING AND COORDINATION Support efforts to provide leadership, planning, and coordination to abate the opioid epidemic through activities, programs, or strategies that may include, but are not limited to, the following: l. Community regional planning to identifr goals for reducing harms related to the opioid epidemic, to identify areas and populations with the greatest needs for treatment intervention services, or to support other strategies to abate the opioid epidemic described in this opioid abatement strategy list. 2. A government dashboard to track key opioid-related indicators and supports as identified through collaborative community processes. 3. Invest in infrastructure or staffing at government or not-for-profit agencies to support collaborative, cross-system coordination with the purpose of preventing overprescribing, opioid misuse, or opioid overdoses, treating those with OUD and any co-occurring SUDiIVIH conditions, co-usage, and/or co-addiction, supporting them in treatment or recovery, connecting them to care, or implementing other strategies to abate the opioid epidemic described in this opioid abatement strategy list. 4. Provide resources to staff government oversight and management of opioid abatement programs. K. TRAINING In addition to the training referred to in various items above, support training to abate the opioid epidemic through activities, programs, or strategies that may include, but are not limited to, the following: l. Provide funding for staff training or networking programs and services to improve the capability of government, community, and not-for-profit entities to abate the opioid crlsts. 2. Invest in infrastructure and staffing for collaborative cross-system coordination to prevent opioid misuse, prevent overdoses, and treat those with OUD and any co- occurring SUDAvIH conditions, co-usage, and/or co-addiction, or implement other 10 strategies to abate the opioid epidemic described in this opioid abatement strategy list (e.g., health care, primary care, pharmacies, PDMPs, etc.). L. RESEARCH Support opioid abatement research that may include, but is not limited to, the following: l. Monitoring, surveillance, and evaluation of programs and strategies described in this opioid abatement strategy list. 2. Research non-opioid treatment of chronic pain. 3. Research on improved service delivery for modalities such as SBIRT that demonstrate promising but mixed results in populations vulnerable to opioid use disorders. 4. Research on innovative supply-side enforcement efforts such as improved detection of mail-based delivery of synthetic opioids. 5. Expanded research on swift/certain/fair models to reduce and deter opioid misuse within criminal justice populations that build upon promising approaches used to address other substances (e.g. Hawaii HOPE and Dakota 24/7). 6. Research on expanded modalities such as prescription methadone that can expand access to MAT. 1l Adams Countv Adams County Hatton Lind othello Ritzville Washtucna Asotin Countv Asotin County Asotin Clarkston Benton Countv Benton Benton City Kennewick Prosser Richland West Richland EXHIBIT B 0.L638732475o/o countyTotal: 0.1638732475% 0.4694498386% Total: 0.4694498386% 1.484883t892o/o os4Ls650564% O.47567795L7o/o o.o4s9360490% County Total:2.s480622463% O.74349L4485o/o Chelan CounW Chelan County Cashmere Chelan Entiat Leavenworth Wenatchee Clallam Countv 0.2968333494% County Total: t.0403247979o/o Clallam County t.307698340L% Forks Port les o.4598370527% Sequim countyTotal: I.7675353928% *** - Local Government appears in multiple counties B-1 Clark Countv Clark County Battle Ground Camas La Center Ridgefield Vancouver Washougal Woodland*** Yacolt Columbia CounW Columbia Co Dayton Starbuck Cowlitz Countv Cowlitz County Castle Rock Kalama Kelso Longview Woodland*** EXHIBIT B County Total: 2. County Total:6.78L203r452% 0.056L699537o/o CountyTotal: 0.0561699537% 4.5149775326% o.L384729857% 0.269t592724% L.7306605325% 0.L279328220% 7.72269459900/o o.t33LL45270% o.6162736905% 4720828L65% o.3932L75r75% Douglas Countv Douglas County Coulee Dam*** East Wenatchee Mansfield Rock lsland Waterville Ferry Countv Ferry County Republic 0.07998L0865% CountyTotal: 0.473L986040% o.L1.53487994% County Totaf : 0.t153487994% *** - Local Government appears in multiple counties B-2 EXHIBIT B Franklin Countv Franklin County Connell Kahlotus Mesa Pasco County Total: Garfield Countv Garfield Cou Pomeroy County Total: Grant Countv Grant Cou Coulee City Coulee Dam*** Electric City Ephrata Grand Coulee Hartline Krupp Mattawa Moses Lake Qui RoyalCity Soap Lake Warden Wilson Creek 0.336t237L44% 0.42780560650/o 0.76392932LO% 0.O32L9822O9o/o 0.032L982209% O.9932572t67o/o O.2O782939090/o Total: L.2OL0866O76o/o *** - Local Government appears in multiple counties B-3 EXHIBIT B Gravs Harbor Countv Grays Aberdeen Cosmopolis Elma Hoquiam McCleary Montesano Oakville Ocean Shores Harbor County 0.9992429L38% 0.249L525333o/o lsland CounW lsland Cou Coupeville Langley Oak Harbor County Total:L.248395447t% O.68204226100/o 0.25Lt55043L% countyTotal: 0.9331973O4L% o.44t7137380% Total: O.ML7L3738O% Jefferson County Jefferson Cou Port Townsend *** - Local Government appears in multiple counties B-4 Kins Countv EXHIBIT B King County 13. Algona Auburn*** Beaux Arts Village Bellevue Black Diamond Bothell* * * Burien Carnation Hill Covington Des Moines Duvall Enumclaw*** FederalWay Hunts Point lssaquah Kenmore Kent Kirkland Lake Forest Park Ma le Val Medina Mercer lsland Milton*** Newcastle Normandy Park North Bend Pacific* * * Redmond Renton Sammamish SeaTac Seattle Shoreline Skykomish ualmie Tukwila Woodinville Yarrow Point CountyTotal: 26. 9743722662% 0.26227749L7% L.t300592573% o.L82L6027t6% 0.027096292r% o.oLt8t34406% 0.LL797645260/o O.05377683260/o 0.306L452240% o.7875240LO7% 0.020444L024% o.5377397676% 0.5453525246% 0.O525439t24o/o o.oo9376L587% o.r7sL79748L% 0.0033117880% o.4839486007% O.76525269200/o O.02243690900/o 0.748ts5t278% 6,60324038L6% 0.0435834501% 0.0649L6448L% 03032205739% 0.01855L6364% *** - Local Government appears in multiple counties B-5 0505653608% ffi EXHIBIT B Kitsap CounW Kitsap County Bainbridge lsland Bremerton Port Orchard Poulsbo Kittitas CounW Kittitas Cou Cle Elum Ellensbu Kittitas Ros South Cle Elum Klickitat Countv Klickitat County Bingen Goldendale White Salmon Lewis Countv Lewis County Centralia Chehalis Morton Mossyrock Napavine Pe Ell Toledo Vader Winlock county Totaf : o.48tL529598% 2.6294133668% 0.L364686074% 0.6193374389o/o o.Loo9497L62% o.0773748246% Total: 3.5635439479% 0.3855704683% o.o9s58249Ls% o.22LL673457% Total: O.22LL673457% L.0777377479% 0.19099903s3% CountyTotal: L.2687367832Yo *** - Local Government appears in multiple counties 8-6 ffi EXHIBIT B Lincoln County Lincoln County Almira Creston Davenport Ha Odessa Reardan Sprague Wilbur CountyTotal: 0. Mason CounW Mason County Shelton CountyTotal: 0. Okanogan Countv Okanogan County Brewster Conconully Coulee Dam**{' Elmer Nespelem Okanogan Omak Oroville Pateros Riverside Tonasket Winthrop Pacific Countv Pacific Cou llwaco Long Beach South Bend Total: 0.6L45O43345% o.4895416466% County Total: 0.48954t6466% o.r7L2669645% L7L2669645% 0.80899L8012% 0.L239t79888% 9329097900% o.6745043345% *** - Local Government appears in multiple counties B-7 EXHIBIT B Pend Oreille Countv Pend Oreille Co Cusick lone Metaline Metaline Falls Newport Pierce Countv Pierce County San Juan Countv San Juan County Friday Harbor 0.2566374940% 66374940% 7.23rOL64020% o.2rot495L7L% Auburn***0.o628522rL2% Bonney Lake o.Lt907738640/o Buckley Carbonado DuPont Eatonville Edgewood o.oo480L679L% Enumclaw***0.0000000000% Fife 0.1955185481% Fircrest Gig Harbor 0.085995334s% Lakewood 0.s2s3640894% Milton*** Orting Pacific*** Puyallup 0.38457048L4% Egv - Ruston South Prairie Steilacoom Sumner o.ro83r57569% Tacoma 3.2816374677% U Place 0.0353733363% Wilkeson county Total: t2.o34523687 O% CountyTotal: 0.2L0149577!% *** - Local Government appears in multiple counties B-8 ffi EXHIBIT B Skaeit Countv Skagit County Anacortes Burlington Concrete Hamilton La Conner n Mount Vernon Sedro-Woolley Skamania Countv Skamania County North Bonneville Stevenson Snohomish CounW Snohomish Cou Cou Total: 0.L63L93t925o/o L.O52602396L% 0.I7749629060/o o.LL4686L66L% o.280r06366s% o.o66Lt4635L% 700s8544% o.L63L937925% 6.90s441s622% Mukilteo Snohomish Stanwood Sultan Woodway Arlington o.2620524080% Bothell* **0.2654558588% Brier Edmonds 0.30s8935009% Everett 7.92s836324L% Gold Bar Granite Falls lndex Lake Stevens o.t38520289L% Lynnwood 0.7704629214To Marysville o.3945067827% MillCreek 0.12279395460/o Monroe 0.177L62t898Yo Mountlake Terrace 0.2108935805% 0.2s6L790702% o.086L097964% Total: 7L.82L3O83387% *** - Local Government appears in multiple counties B-9 EXHIBIT B Spokane Countv kane Cou Airway Heights Cheney Deer Park Fairfield Latah Liberty Lake Medical Lake Millwood Rockford Spangle Spokane Spokane Valley Waverly County Total: Stevens CounW Stevens County Chewelah Colville Kettle Falls Marcus Northport Springdale Thurston CounW Thurston Cou Bucoda Lacey Olympia Rainier Tenino Tumwater Yelm Wahkiakum Countv Wahkiakum County Cathlamet 0.747924OI79o/o County Totaf : O.7479240179% 2.3258492094% 0.234862722t% o.603942338s% 0.206s982350% CountyTotal: 3.37L2525050% 5.56238592920/o o.t238454349% 0.0389636519% 3.08720782870/o o.o6842t7500% 8.8808245947% o.o595582L97% CountyTotal: 0.0596582197% *** - Local Government appears in multiple counties B-10 EXHIBIT B Walla Walla Countv Walla Walla County College Place Prescott Waitsburg Walla Walla Whatcom Countv Whatcom County Bellingham Blaine Everson Ferndale Lynden Nooksack Sumas Whitman CounW Whitman County Albion Colfax Colton Endicott Farmington Garfield LaCrosse Lamont Malden Oakesdale Palouse Pullman Rosalia st. John Tekoa Uniontown 0.3L40768654% countyTotal: 0.8684638948% o.5543870294% 1.34526373o60/o 0.89786L4577% o.0646LOL89L% O.0827Lt56L2o/o Total: 2.3904469386% 0.2626805837% O.22L483749Lo/o CountyTotal: 0.4841543328% *** - Local Government appears in multiple counties B-11 EXHIBIT B Yakima CounW Yakima County L.9388392959% Grandview 0.0530505109% Granger Harrah Mabton Moxee Naches Selah Sunnyside O.L213478384o/o Tieton Toppenish Union Gap 0.6050410539% Totaf : 2.7L9288799t% Wapato Yakima Zillah *** - Local Government appears in multiple counties B-12 FJ Xf-r -lJod flo+o KING COUNTY REGIONAL AGREEMENT King County intends to explore coordination with its cities and towns to facilitate a Regional Agreement for Opioid Fund allocation. Should some cities and towns choose not to participate in a Regional Agreement, this shall not preclude coordinated allocation for programs and services between the County and those cities and towns who elect to pursue a Regional Agreement. As contemplated in C.5 of the MOU, any Regional Agreement shall comply with the terms of the MOU and any Settlement. If no Regional Agreement is achieved, the default methodology for allocation inC.4 of the MOU shall apply. EXHIBIT B GREATER COLUMBIA OPIOID ABATEMENT COUNCIL MEMORANDIUM OF UNDERSTANDING MEMORANDUM OF UNDERSTANDING BETWEEN THE GREATER COLUMBIA REGION MUNICIPALITIES TO ESTABLISH AN OPIOID ABATEMENT COUNCIL Whereas, the people of the State of Washington and its communities have been harmed by entities within the Pharmaceutical Supply Chain who manufacture, distribute, and dispense prescription opioids; Whereas, certain Local Governments, through their elected representatives and counsel are engaged in litigation seeking to hold these entities within the Pharmaceutical Supply Chain of prescription opioids accountable for the damage they have caused to the Local Governments; Whereas, Local Governments and elected officials share a common desire to abate and alleviate the impacts of harms caused by these entities within the Pharmaceutical Supply Chain throughout the State of Washington, and strive to ensure that principals of equity and equitable service delivery are factors considered in the allocation and use of Opioid Funds; Whereas, Certain Local Governments engaged in litigation and the other cities and counties in Washington desire to agree on a form of allocation for Opioid Funds they receive from entities within the Pharmaceutical Supply Chain; Whereas, Local Governments who receive funds that are governed by the August 2O22One Washington Memorandum of Understanding are required to participate in an Opioid Abatement Council to oversee and approve the plans forthe spending of those funds; Now therefore, the Local Governments within the Greater Columbia Region enter into this Memorandum of Understanding ("MOU") relating to the formation of an Opioid Abatement Council. A. Definitions As used in this MOU: 1. "Administering Agency" shall mean the Greater Columbia Behavioral Health, LLC. 2. "Approved Purposes" shall mean the strategies specified and set forth in the Opioid Abatement Strategies attached as Exhibit A. 3. "Greater Columbia Region" shall mean the allocation region as determined by the August 2022 Qne Washington Memorandum of Understanding between Washington Municipalities (One Washington MOU) made up of the following counties: Asotin, Benton, Colurnbia, Franklin, Garfield, Kittitas, Walla Walla, Whitman, and Yakima. 4. "Participating Local Governments" shall mean those local governments that have chosen to sign on to the One Washington MOU. The Participating Local Governments for this MOU are: Asotin County, Benton County, Columbia County, Franklin County, Garfield County, Kittitas County, Walla Walla County, Whitman County, Yakima County, Kennewick, Richland, West Richland, Pasco, Ellensburg, Walla Walla, Pullman, Grandview, Sunnyside and Yakima. 5. "Opioid Abatement Council (OAC)" shall mean the group of representatives from the municipalities receiving funds within the Greater Columbia Region to oversee Opioid fund allocation, distribution, expenditures and dispute resolution as well as other responsibilities laid out in this MOU. See also One Washington MOU. 6. "Opioid Funds" shall mean monetary amounts obtained through a Settlement as defined in the One Washington MOU. B. Opioid Abatement Council a. All Participating Local Governments may have one representative on the OAC subject to the requirements detailed in the one Washington MOU.. b" The OAC shall meet on a quarterly basis or as needed, as determined by the Administering Agenry. c. All Participating Local Governments will submit a spending plan to the OAC that complies with the Approved Purposes as outlined in Exhibit A, prior to the Participating Local Governments' expenditure of any Opioid funds. d. Responsibilities of the oAC: i. Overseeing distribution of Opioid Funds from Participating Local Governments to programs and services within the Allocation Region for Approved Purposes. ii. Annual review of expenditure reports from Participating Local Jurisdictions within the Allocation Region for compliance with Approved Purposes and the terms of this MOU and any Settlement. To facilitate this process, each Participating Local Government shall submit monthly expenditure reports for each month that funds were distributed, iii. Reporting and rnaking publicly available all decisions on Opioid Fund allocation applications, distributions and expenditures by the OAC or directly by Participating Local Governments' iv. Developlng and maintaining a centralized public dashboard or other repository for the publication of expenditure data from any Participating Local Government that receives Opioid Funds, and for expenditures by the OAC in that Allocation Region, which it shall update at least annually. v. Hearing complaints by Participating Local Governments within the Allocation Region regarding alleged failure to: 1. Use Opioid Funds for Approved Purposes or 2. Comply with reporting requirements. vi. lf necessary, requiring and collecting additional outcome related data from Participating Local Governments to evaluate the use of Opioid Funds, and all Participating Local Governrnents shall comply with such requirements. e. lf the OAC concludes that a Participating Local Government's expenditure of its allocation of Opioid Funds did not comply with the Approved Purposes listed in Exhibit A or the terms of this MOU, or that the Participating Local Government otherwise misused its allocation of Opioid Funds, the OAC may take remedial action against the alleged offending Participating Local Government. Such remedialaction is leftto the discretion of the OAC and may include withholding future Opioid Funds owed to the offending Participating Local Government or requiring the offending Participating Local Government to reimburse improperly expended Opioid Funds back to the OAC to be re-allocated to the remaining Participating Local Governments within the Region. f. All Participating Local Governments and the OAC shall maintain all records related to the receipt and expenditure of Opioid Funds for no less than five (5) years and shall make such records available for review by any other Participating Local Government or OAC, or the public. Records requested by the public shall be produced in accordance with Washington's Public Records Act RCW 4256.00I et seq. Records requested by another Participating Local Government or an OAC shall be produced within twenty-one (21) days of the date the record request was received. This requirement does not supplant any Participating Local Government or OAC's obligations under Washington s Public Records Act RO / 42.56.001 et seq- g. Each Participating Local Government may elect to have its share re-allocated to the OAC. The oAC will then utilize this share for the benefit of Participating Local Governments within the Allocation Region, consistent with the Approved Purposes set forth in Exhibit A. A Participating Local Government's election to forego its allocation of Opioid Funds shall apply to all future allocations unless the Participating Local Government notifies the OAC otherwise. lf a Participating Local Government elects to forego its allocation of the Opioid Funds, the Participating Local Government shall be excused from the reporting requirements set forth in this Agreement. i. ln the case where Participating Local Governments chose to forego their allocation of Opioid fund, the OAC shall be responsible for: L Approving or denying proposals by Participating Local Governments or community groups to the OAC for use of Opioid Funds within the Allocation Region. 2. Directing the Trustee to distribute Opioid Funds for use by Participating Local Governments or community groups whose proposals are approved by the OAC, 3. Administrating and maintaining records of all OAC decisions and distributions of Opioid Funds. h. Participating Local Governments will reserve 10% of the Opioid Funds received for administrative costs related to the OAC. The OAC will provide an annual accounting for actual costs, and any remaining funds may then be used for the Participating Local Government's Approved purpose. The Administering Agency will be responsible for providing staffing and administrative support for the OAC. MEMORANDUM OF UNDERSTANDING BETWEEN THE GREATER COLUMBIA REGION MUNICIPALITIES TO ESTABLISH AN OPIOID ABATEMENT COUNCIL This Memorandum of Understandins between the Greater an Opioid Abatement Council is sign-eU ,n, 1W day of umbia Region Municipalities to Establish 2023 by: Name & On Behalf of Exhibit A OPIOID ABATEMENT STRATEGIES Participating Local Governments that receive a direct payment maintain full discretion over the use and distribution of their allocation of Opioid Funds, provided the Opioid Funds are used solely for Approved Purposes. Reasonable administrative costs for a Participating Local Government to administer its allocation of Opioid Funds shall not exceed actual costs or 10% of the Participating Local Government's allocation Opioid Funds, whichever is less. PART ONE: TREATMENT A. TREAT OPIOID USE DISORDER (OUD} Support treatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use Disorder or Mental Health (SUD/MH) conditions. Co-usage, and/or co-addiction through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 1. Expand availability of treatment for OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction. lncluding all forms of Medication-Assisted Treatment (MAT) approved by the U.S. Food and Drug Administration. 2. Support and reimburse services that include the full Arnerican Society of Addiction Medicine (ASAM) continuum of care for OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction, including but not limited to: a.Medication-Assisted Treatment (MAT); b. Abstinence-based treatmenU c. Treatment, recovery, or other services provided by states, subdivisions, community health centers; non-for-profit providers; or for-profit providers; d. Treatment by providers that focus on OUD treatment as well as treatment by providers that offer OUD treatment along with treatment for other 5UD/MH condition, co-usage, andf or co-addiction; or Evidence- informed residential services programs, as noted below 3. Expand telehealth to increase access to treatment for OUD and any co-occurring suD/MH conditions, co-usage, and/or co-addiction, including MAT, as well as counseling, psychiatric support, and other treatment and recovery support services. 4. lmprove oversight of opioid Treatment Programs {OTPs} to assure evidence-based, evidence-informed, or promising practices such as adequate methadone dosing. 5. Support mobile intervention, treatment, and recovery services, offered by qualified professional and service providers, such as peer recovery coaches, for persons with OUD and any co-occurring 5UD/MH conditions, co-usaBe, and/or co-addiction and for persons who have experienced an opioid overdose. 6' Support treatment of mental health trauma resulting from the traumatic experiences of the opioid user (e.g., violence, sexual assault, human trafficking or adverse childhood experiences) and family members (e.g., surviving family members after an overdose or overdose fatality), and training of health care personnel to identify and address such trauma. 7. support detoxification (detoxJ and withdrawal management services for persons with OUD and any co-occurring SUD/MH conditions, co-usage, andf or co-addiction, including medical detox, referral to treatment, or connections to other services or supports. 8' Support training on MAT for health care providers, students, or other supporting professionals, such as peer recovery coaches or recovery outreach specialists, including telementoring to assist community-based providers in rural or underserved areas. 9. Support workforce development for addiction professionals who work with persons with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction. 10' Provide fellowships for addiction medicine specialists for direct patient care, instructors, and clinical research for treatments. 11. Provide funding and training for clinicians to obtain a waiver under the federal Drug Addiction Treatment Act of 2000 (DATA 2000) to prescribe MAT for OUD, and provide technical assistance and professional support to clinicians who have obtained a DATA 2000 waiver. 12. Support the dissemination of web-based training curricula, such as the American Academy of Addiction Psychiatry's Provider Clinical Support Service-Opioids web- based training curriculum and motivational interviewing. 13. Support the development and dissemination of new curricula, such as the American Academy of Addiction Psychiatry's Provider Clinical Support Service for Medication- Assisted Treatment. B. SUPPORT PEOPLE IN TREATMENT AND RECOVERY Support people in treatment for and recovery form OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction through evidenced-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 1. Provide the full continuum of care of recovery services for OUD and any co0occurrinf SUD/MH condition, co-usage, and/or co-addiction, including supportive housing, residential treatment, medical detox services, peer support services and counseling, community navigators, case management, and connections to community-based services. Z. Provide counseling, peer-support, recovery case management and residential treatment with access to medications for those who need it to persons with OUD and any co-occu rring SUDIM H co nditions, co-r,lsa ge, and / or co-ad diction. 3. Provide access to housing for people with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction, including supportive housing, recovery housing, housing assistance programs, or training for housing providers. 4. Provide community support services. lncluding social and legal services, to assist in deinstitutionalizing persons with OUD and any co-occurring SUD/MH conditions, co- usage, andf or co-addiction. 5. Support or expand peer-recovery centers, which may include support groups, social events, computer access, or other services for persons with OUD and anyco-occurring SUD/MH conditions, co-usage, andlor co-addiction. 6. Provide employment training or educational services for persons in treatment for or recovery form OUD and any co-occurring SUD/MH conditions, co-usage, and/or co- addiction. 7, ldentify successful recovery programs such as physician, pilot, and college recovery programs, and provide support and technical assistance to increase the number and capacity of high-quality programs to help those in recovery. 8. Engage non-profits, faith-based communities, and community coalitions to support people in treatment and recovery and to support family members in their efforts to manage the opioid user in the family. 9. Provide training and development of procedures for government staff to appropriately interact and provide social and other services to current and recovering opioid users, including reducing stigma. L0. Support stigma reduction efforts regarding treatment and support for persons with OUD, including reducing the stigma on effective treatment. C. CONNECT PEOPTE WHO NEED HEIP TO THE HEIP THEY NEED (CONNECTIONS TO CAREI Provide connections to care for people who have - or are at risk of developing - OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 1.Ensure that health care providers are screening for OUD and other risk factors and know how to appropriately counsel and treat (or refer if necessary) a patient for OUD treatment. Support Screening, Brief lntervention and Referral to Treatment (SBIRT) programs to reduce the transition from use to disorders. Provide training and long-term implementation of SBIRT in key systems (health, schools, colleges, criminaljustice, and probation), with a focus on youth and young adults when transition from misuse to opioid disorder is common, Purchase automated versions of SBIRT and support ongoing costs of the technology. Support training for emergency room personnel treating opioid overdose patients on post-discharge planning including community referrals for MAT, recovery case management or support services. 6' Support hospital programs that transition persons with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction, or person who have experienced an opioid overdose, into comrnunity treatment or recovery services through a bridge clinic or similar approach. 7. Support crisis stabilization centers that serve as an alternative to hospital emergency departments for persons with OUD and any co-occurring SUD/MH conditions, co=usage, and f or co-addiction or persons that have experienced an opioid overdose.8. Support the work of Emergency Medical Systems, including peer support specialists, to connect individuals to treatment or other appropriate services following an opioid overdose or other opioid=related adverse event. 9' Provide funding for peer support specialists or recovery coaches in emergency departrnents, detox facilities, recovery centers, recovery housing, or similar settings; offer services, supports, or connections to care to persons with OUD and any co- occurring SUD/MH conditions, co-usage, and/or co-addiction or to persons who have experienced an opioid overdose. 10, Provide funding for peer navigators, recovery coaches, care coordinators, or care managers that offer assistance to persons with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction or to person who have experienced on opioid overdose. 11- Create or support school-based contacts that parents can engage w1h to seek imrnediate treatment services for their child; and support prevention, intervention, treatment, and recovery programs focused on young people. 12. Develop and support best practices on addressing oUD in the workplace. 13. Support assistance programs for health care providers with oUD. L4' Engage non-profits and the faith community as a system to support outreach for treatment. 15' Support centralized call centers that provide information and connections to appropriate services and supports for person s with OUD and any co-occurring 5UD/MH conditions, co-usage, an/or co-addiction- 16. Create or support intake and call centers to facilitate education and access to treatment, prevention, and recovery services for persons with ouD and any co_ occu rring SU D/M H cond ition, co-usage, and / or co-addiction. 2. 3. 4. 5. 17. Develop or support a National Treatment Availability Clearing house - a multistate/nationally accessible database whereby health care providers can list locations for currently available in-patient and out-patient OUD treatment services that are accessible on a real-time basis by persons who seek treatment. D, ADDRESS THE NEEDS OF CR|M|NAL-JUSTTCE-TNVOLVED PERSONS Address the needs of persons with OUD and any co-occurring 5UD/MH conditions, co-usage, and/or co-addiction who are involved - or are at risk of becoming involved - in the criminal justice system through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: L. Support pre-arrest or post-arrest diversion and deflection strategies for persons with OUD and any co-occurring SUD/MH conditions, co-usage, andfor co-addiction, including established strategies such as: a. Self-referral strategies such as the Angel Programs or the Police Assisted Addiction Recovery lnitiative (PAARI); b. Active outreach strategies such as the Drug Abuse Response Team (DART) model; c. "Naloxone Plus" strategies, which work to ensure that individuals who have received naloxone to reverse the effects of an overdose are then linked to treatment programs or other appropriate services; d. Officer prevention strategies, such as the Law Enforcement Assisted Diversion (LEAD)model; e. Officer intervention strategies such as the Leon County, Florida Adult Civil Citation Network or the Chicago Westside Narcotics Diversion to Treatment lnitiative; f. Co-responder and/or alternative responder models to address OUD-related 911 calls with greater SUD expertise and to reduce perceived barriers associated with law enforcement 911 responses; or g. County prosecution diversion programs, including diversion officer salary, only for counties with a population of 50,000 or less. Any diversion services in matters involving opioids must include drug testing, monitoring, ortreatment. 2. Support pre-trial services that connect individuals with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction to evidence-informed treatment, including MAT, and related services. 3. Support treatment and recovery courts for persons with OUD and any co-occurring SUD/MH conditions, co-usage, andf or co-addiction, but only if these courts provide referrals to evidence-informed treatment, including MAT. 4. Provide evidence-informed treatment, including MAT, recovery support, or other appropriate services to individuals with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction who are incarcerated in jail or prison, 5. Provide evidence-informed treatment, including MAT, recovery support, or other appropriate services to individuals with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction who are leaving jail or prison have recently left lail or prison, are on probation or parole, are under community corrections supervision, or are in re-entry programs or facilities. 5. Support critical time interventions (CTl), particularly for individuals living with dual- diagnosis OUD/serious mental illness, and services for individuals who have immediate risks and service needs and risks upon release from correctional settings.7. Provide training on best practices for addressing the needs of criminal-justice- involved persons with oUD and any co-occurring suD/MH conditions, co-usage, and/or co-addiction to law enforcement, correctional, or judicial personnel or to providers of treatment, recovery, case management, or other services offered in connection with any of the strategies described in this section. E. INCLUDING BAEIES WTTH NEONATAL ABSTINENCE SYNDROME Address the needs of pregnant or parenting women with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction, and the needs of their families, including babieswith neonatal abstinence syndrome, through evidence-based, evidence-informed, or promising prograrns or strategies that may include, but are not limjted to, the following: 1. Support evidence-based, evidence-informed, or promising treatment, including MAT, recovery services and supports, and prevention services for pregnant women - or women who could become pregnant - who have OUD and y any co-occurring SUD/MH conditions, co-usage, and/or co-addiction, and other measures to educate and provide support to families affected by Neonatal Abstinence syndrome.2. Provide training for obstetricians or other healthcare personnel that work with pregnant women and their families regarding treatment of OUD and any co-occurring SU D/M H cond itions, co-usage, a n d/or co-addiction. 3' Provide training to health care providers who work with pregnant or parenting women on best practices for compliance with federal requirements that children born with Neonatal Abstinence Syndrome get referred to appropriate services and receive a plan ofsafe care. 4. Provide enhanced support for children and family members suffering trauma as a result of addiction in the family; and offer trauma-informed behavioral health treatrnent for adverse childhood events. 5. offer enhanced family supports and home-based wrap-around services to persons with OUD and any co-occurring 5UD/MH conditions, co-usage, and/or co-addiction, including but not limited to parent skiils training. 6' Support for Children's Services - Fund additional positions and services, including supportive housing and other residential services, relating to children being removed from the home and/or placed in foster care due to custodial opioid use. PART TWO: PREVENTION F. PREVENT OVER.PRESCRIBING AND ENSURE APPROFRIATE PRESCRIBING AND DISPENSING OF OPIODS Support efforts to prevent over-prescribing and ensure appropriate prescribing and dispensing of opioids through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: L. Training for health care providers regarding safe and responsible opioid prescribing, dosing, and tapering patients off opioids. 2. Academic counter-detailing to educate prescribers on appropriated opioid prescribing. 3. Continuing Medical Education {CM E} on appropriate prescribing of opioids. 4. Support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain. 5. Support enhancements or improvements to Prescription Drug Monitoring Programs (PSMPs), including but not limited to improvements that: A. lncrease the number of prescribers using PDMPs; B. lmprove point-of-care decision-making by increasing the quantity, quality, or format of data available to prescribers using PDMPs or by improving the interface that prescribers use to access PDMP data, or both; or C. Enable states to use PDMP data in support of surveillance or intervention strategies, including MAT referrals and follow-up for individuals identified within PDMP data as likely to experience OUD. 6. Development and implementation of a national PDMP - Fund development of a multistate/national PDMP that permits inforrnation sharing while providing appropriate safeguards on sharing of private health information, including but not limited to: a. lntegration of PDMP data with electronic health records, overdose episodes, and decision support tools for health care providers relating to OUD. b. Ensuring PDMPs incorporate available overdose/naloxone deployment data, including the United States Department of Transportation's Emergency Medical Technician overdose database. 7. lncrease electronic prescribing to prevent diversion or forgery. 8. Educate Dispensers on appropriate opioid dispensing. G. PREVENT MISUSE OF OPIOIDS Support efforts to discourage or prevent misuse of opioids through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 1. Corrective advertising or affirmative public education campaigns based on evidence. 2. Public education relating to drug disposal. 3. Drug take-back disposal or destruction programs. 4. Fund community anti-drug coalitions that engage in drug prevention efforts.5' Support community coalitions in implementing evidence-informed prevention, such as reduced social access and physical access, stigma reduction - including staffing, educational campaigns, support for people in treatment or recovery, or training of coalitions in evidence-informed implementation, including the Strategic prevention Framework developed by the U.5. Substance Abuse and Mental Health Services Ad ministration (SAMHSA). 5. Engage non-profits and faith-based communities as systems to support prevention.7. Support evidence-informed school and community education programs and campaigns for students. Families, school employees, schoolathletic programs, parent- teacher and student associations, and others. 8. School-based or youth-focused programs or strategies that have demonstrated effectiveness in preventing drug misuse and seem likely to be effective in preventing the uptake and use of opioids. 9. Support community-based education or intervention services for families, youth, and adolescents at risk for oUD and any co-occurring suD/MH conditions, co-usage, and/or co-addiction. 10. support evidence-informed programs or curricula to address mental health needs of young people who may be at risk of misusing opioids or other drugs, including emotional modulation and resilience skills. 11. Support greater access to mental health services and supports for young people, including services and supports provided by school nurses or other school staff, to address mental health needs in young people that (when not properly addressed) increase the risk of opioid or other drug misuse. H. PREVENT OVERDOSE DEATI{S AND OTHER HARMS Support efforts to prevent or reduce overdose deaths or other opioid-related harms through evidence-based, evidence-informed, or promising programs or strategies that may include, but are not limited to, the following: 7- lncrease availability and distribution of naloxone and other drugs that treat overdoses for first responders, overdose patients, opioid users, families and friends of opioid users, schools, community navigators and outreach workers, drug offenders upon release from jail/prison, or other members of the general public.2' Provision by public health entities of free naloxone to anyone in the community, including but not limited to provision of intra-nasal naloxone in settings where other options are not available or allowed. 3' Training and education regarding naloxone and other drugs that treat overdoses forfirst responders, overdose patients, patients taking opioids, families, schools, and other members of the general public. 4' Enable school nurses and other school staff to respond to opioid overdoses, and provide them with naloxone, training, and support. 5. Expand, improve, or develop data tracking software and applications for overdoses/nal oxone revivals. 6. Public education relating to emergency responses to overdoses. 7 - Public education relating to immunity and Good Samaritan laws, 8. Educate first responders regarding the existence and operation of immunity and Good Samaritan laws. 9. Expand access to testing and treatment for infectious diseases such as HIV and Hepatitis C resulting from intravenous opioid use. i-0. Support mobile units that offer or provide referrals to treatment, recovery supports, health care, or other appropriate services to persons that use opioids or persons with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction. 11. Provide ffaining in treatment and recovery strategies to health care providers, students, peer recovery coaches, recovery outreach specialists, or other professionals that provide care to persons who use opioids or persons with OUD and any co- occurri ng 5U D/M H conditions, co-usage, and / or co-add iction. 12. Support Screening for fentanyl in routine clinical toxicology testing PART THREE: OTHER STRATEGIES I. FIRST RESPONDERS ln addition to items C8, Dl- through D7, Ht, H3 and H8, support the following: 1. Current and future law enforcement expenditures relating to the opioid epidemic. 2. Educate law enforcement or other first responders regarding appropriate practices and precautions when dealing with fentanyl or other drugs. l. lfApERSHtp. PLANN|NG ANp COORDTNATTON Support efforts to provide leadership, planning, and coordination to abate the opioid epidemic through activities, programs, or strategies that may include, but are not limited to, the following: 1. Community regional planning to identify goals for reducing harms related to the opioid epidemic, to identify areas and populations with the greatest needs for treatment intervention services, or to support other strategies to abate the opioid epidemic described in this opioid abatement strategy list. 2. A government dashboard to track key opioid-related indicators and supports as identified through collaborative community processes. 3.lnvest in infrastructure or staffing at government or not-for-profit agencies to support collaborative, cross-system coordination with the purpose of preventing overprescribing, opioid misuse, or opioid overdoses, treating those with oUD and any co-occurring suD/MH conditions, co-usage, and/or co-addiction, supporting them in treatment or recovery, connecting them to care, or implementing other strategies to abate the opioid epidernic described in this opioid abatement strategy list. 4' Provide resources to staff government oversight and management of opioid abatement programs. K. TRAINTNG ln addition to the training referred to in various items above, support training to abate the opioid epidemic through activities, programs, or strategies that may include, but are not limited to, the following: Provide funding for stafftraining or networking programs and services to irnprove the capability of government, community, and not-for-profit entities to abate the opioid crisis. lnvest in infrastructure and staffing for collaborative cross-system coordination to prevent opioid misuse, prevent overdoses, and treat those with ouD and any co- occurring suD/MH conditions, co-usage, and/or co-addiction, or implement other strategies to abate the opioid epidemic described in this opioid abatement strategy list (e.g., health care, primary care, pharmacies, pDMps, etc.) t. RESEARCH Support opioid abatement research that may include, but is not limited to, the following: L' Monitoring, surveillance, and evaluation of programs and strategies described in this opioid abatement strategy list. 2. Research non-opioid treatment of chronic pain. 3. Research on improved service delivery for modalities such as SBIRT that demonstrate promising but mixed results in populations vulnerable to opioid use disorders.4' Research on innovative supply-side enforcement efforts such as improved detection of mail-based delivery of synthetic opioids, 5. Expanded research on swift/certain/fair models to reduce and deter opioid misuse within criminal justice populations that build upon promising approaches used to address other substances (e.g. Hawaii HOpE and Dakota 24/71.6. Research on expanded modalities such as prescription methadone that can expand access to MAT. 1. 2. EXHIBIT C COMMUNITY HEALTH IMPROVEMENT PLAN AND ONE WASHINGTON MOU OPIOID ABATEMENT STRATEGI ES CROSSWALK ANALYSIS Research Training Leadership, ptanning and coordination First responders Prevent overdose deaths and other harms Prevent misuse of opioids Prevent over-prescribing and ensure appropriate prescribing and dispensing of opioids Address the needs of pregnant or parenting women and their famities, inctuding babies with neonataI abstinence syndrome Address the needs of cri mi nat-j ustice-invotved persons Connect people who need hetp to the hetp they need (connections to care) Support people in treatment and recovery Treat opioid use disorder (ouD) Contractuatty Allowabte Activity Goal2.1 Goat 2.1 Goal2.2 GoaL2.2 Goa[ 2.1 Goat 1.3 Gommunity- ldentified Priority No partial No No partiat Yes No partiat No Partiat Yes Yes Atignment? Not addressed in the CHIP MOU tatks about investing in infrastructure for cross-system cottaboration and CHIP tatks about sustained cross-sector cotlaboration. Not addressed in the CHIP. Chip does not mention first responder training. MOU discusses public education and this coutd atign with resource guide and/or commu n ity conversations. Schoot programming and behavioraI heatth screenings in CHIP if atigned with the goal of OUD prevention woutd fatt within this activiW. CHIP does not include changes in prescribing process. There coutd be crossover with both Goat 3.2 and Goat 3.3. This is not mentioned in the CHIP. Kittitas county priority populations (CHIP) may align with the MOU "peopte who have - or are at risk of devetoping - OUD and any co-occurring conditions." Stigma reduction directty mentioned in both. Peer-support (MOU) could be atigned with Act 2.1.3 (CHIP). "Expand avaitabitity of treatment" and "support mobite intervention" (mou) atigns with "expand mobite and free clinic presence" (CHIP). Notes / Gaps / Opportunities Community Heal.th lmprovement Ptan Goats Goat 3.3 Goat 3.2 Goat 3.1 Goal2.2 Goat 2.1 Goat 1.3 Goat 1.2 Goat 1.1 lncrease age-specific mentaI heatth and substance use services and providers lncrease communication between at[ community partners, parents, and famities to address adolescent specific needs Foster community resitience by increasing the number of protective factors through poticymakers and other community groups to improve access to recreation and activities, childcare facitities, mentoring, and other prevention resources lncrease evidence-based prevention strategies to identified priority poputations Sustained cross-sector cottaboration for stigma reduction and resource awareness Addressing barriers to accessing healthcare services (tanguage, location, literacy, stigma, insurance, cutturat competency, transportation, technology, nontraditionaI heatthcare needs) conduct an assessment on heatthcare workforce needs and improvement strategies Support the efforts around coordinating services for individuats with complex heatth and sociaI needs